非小细胞-话题@MedSci

#非小细胞#

746篇内容 | 6354人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2059653, encodeId=63e42059653e7, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=NCCN临床实践指南：非小细胞肺癌（2017.V9）, objectType=article, longId=115924, objectId=2603115924f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2603115924f1, replyNumber=0, likeNumber=32, createdTime=2018-09-22, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2603115924f1, moduleTitle=NCCN临床实践指南：非小细胞肺癌（2017.V9）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2603115924f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059672, encodeId=caa420596e20f, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=CLIN CANCER RES：ASP8273治疗EGFR突变非小细胞肺癌, objectType=article, longId=123731, objectId=8ca8123e31c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ca8123e31c7, replyNumber=0, likeNumber=69, createdTime=2018-07-02, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ca8123e31c7, moduleTitle=CLIN CANCER RES：ASP8273治疗EGFR突变非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ca8123e31c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059639, encodeId=ced0205963928, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=Cancer Cell:新型“液体活检”！非小细胞肺癌诊断准确率高达近90%, objectType=article, longId=109079, objectId=e6271090e9dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6271090e9dd, replyNumber=0, likeNumber=69, createdTime=2017-09-04, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6271090e9dd, moduleTitle=Cancer Cell:新型“液体活检”！非小细胞肺癌诊断准确率高达近90%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6271090e9dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059660, encodeId=f91520596606f, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=ANN ONCOL：S-1与多西他赛治疗铂基化疗后非小细胞肺癌患者的疗效对比, objectType=article, longId=119384, objectId=6bb111938437, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bb111938437, replyNumber=0, likeNumber=73, createdTime=2017-12-29, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bb111938437, moduleTitle=ANN ONCOL：S-1与多西他赛治疗铂基化疗后非小细胞肺癌患者的疗效对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bb111938437)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059715, encodeId=4d072059e155f, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=Lung Cancer：安罗替尼可改善晚期非小细胞肺癌患者的生活质量, objectType=article, longId=139552, objectId=d0cf13955254, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0cf13955254, replyNumber=0, likeNumber=66, createdTime=2019-05-15, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0cf13955254, moduleTitle=Lung Cancer：安罗替尼可改善晚期非小细胞肺癌患者的生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0cf13955254)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059678, encodeId=032c20596e8ba, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=ADJUVANT研究翻开非小细胞肺癌术后辅助治疗新篇章, objectType=article, longId=124633, objectId=a91b1246334c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a91b1246334c, replyNumber=0, likeNumber=80, createdTime=2018-12-11, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a91b1246334c, moduleTitle=ADJUVANT研究翻开非小细胞肺癌术后辅助治疗新篇章, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a91b1246334c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059692, encodeId=93282059692b3, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=JCO：Nivolumab治疗晚期非小细胞肺癌的5 年随访结果, objectType=article, longId=133426, objectId=9bfb133426b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9bfb133426b8, replyNumber=0, likeNumber=74, createdTime=2019-02-11, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9bfb133426b8, moduleTitle=JCO：Nivolumab治疗晚期非小细胞肺癌的5 年随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9bfb133426b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059690, encodeId=ee8120596907b, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=Sci Rep：转录因子PAX6可作为非小细胞肺癌的预后因子和假定肿瘤抑制基因, objectType=article, longId=133247, objectId=c26d13324ec0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c26d13324ec0, replyNumber=0, likeNumber=76, createdTime=2018-07-24, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c26d13324ec0, moduleTitle=Sci Rep：转录因子PAX6可作为非小细胞肺癌的预后因子和假定肿瘤抑制基因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c26d13324ec0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059704, encodeId=f6672059e04e7, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=ROS1阳性非小细胞肺癌诊断病理专家共识, objectType=article, longId=136615, objectId=e43613661584, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e43613661584, replyNumber=0, likeNumber=32, createdTime=2018-11-19, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e43613661584, moduleTitle=ROS1阳性非小细胞肺癌诊断病理专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e43613661584)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059659, encodeId=d1e7205965907, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=PLoS One：前列腺特异性膜抗原（PSMA）在非小细胞肺癌中的表达, objectType=article, longId=118249, objectId=77211182498e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77211182498e, replyNumber=0, likeNumber=58, createdTime=2018-03-25, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77211182498e, moduleTitle=PLoS One：前列腺特异性膜抗原（PSMA）在非小细胞肺癌中的表达, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77211182498e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059711, encodeId=8d832059e1172, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=JCO：PD-1抑制剂治疗合并自身免疫疾病的非小细胞肺癌患者, objectType=article, longId=138067, objectId=b94913806e3b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b94913806e3b, replyNumber=0, likeNumber=90, createdTime=2018-12-06, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b94913806e3b, moduleTitle=JCO：PD-1抑制剂治疗合并自身免疫疾病的非小细胞肺癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b94913806e3b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059629, encodeId=819c205962965, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=Ann Oncol：我国学者展示非小细胞肺癌的精准治疗方案, objectType=article, longId=105223, objectId=57d310522324, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57d310522324, replyNumber=0, likeNumber=96, createdTime=2017-07-26, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57d310522324, moduleTitle=Ann Oncol：我国学者展示非小细胞肺癌的精准治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57d310522324)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059641, encodeId=753b205964169, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=JCO：激酶抑制剂可作为EGFR突变阳性晚期非小细胞肺癌的一线治疗！, objectType=article, longId=111065, objectId=5e6c111065d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e6c111065d4, replyNumber=0, likeNumber=66, createdTime=2018-02-01, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e6c111065d4, moduleTitle=JCO：激酶抑制剂可作为EGFR突变阳性晚期非小细胞肺癌的一线治疗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e6c111065d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059717, encodeId=eb0f2059e17e9, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=NEJM：Atezolizumab一线治疗转移性非鳞状非小细胞肺癌, objectType=article, longId=140057, objectId=430314005e99, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=430314005e99, replyNumber=0, likeNumber=55, createdTime=2019-05-19, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=430314005e99, moduleTitle=NEJM：Atezolizumab一线治疗转移性非鳞状非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=430314005e99)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059693, encodeId=536420596930a, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=肺癌脑转移该如何治疗？国内非小细胞肺癌脑转移调研发布, objectType=article, longId=134105, objectId=ced913410553, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ced913410553, replyNumber=0, likeNumber=89, createdTime=2018-10-30, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ced913410553, moduleTitle=肺癌脑转移该如何治疗？国内非小细胞肺癌脑转移调研发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ced913410553)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059694, encodeId=888d2059694be, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=Lancet oncol：ALT-803（IL-15强激动剂）联合nivolumab用于转移性非小细胞肺癌安全性可耐受, objectType=article, longId=134404, objectId=edd7134404aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edd7134404aa, replyNumber=0, likeNumber=64, createdTime=2018-05-28, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edd7134404aa, moduleTitle=Lancet oncol：ALT-803（IL-15强激动剂）联合nivolumab用于转移性非小细胞肺癌安全性可耐受, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edd7134404aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059640, encodeId=0bd3205964030, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=Oncotarget：转谷氨酰胺酶2在非小细胞肺癌患者中的预后价值, objectType=article, longId=110376, objectId=27d31103e603, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27d31103e603, replyNumber=0, likeNumber=54, createdTime=2018-02-20, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27d31103e603, moduleTitle=Oncotarget：转谷氨酰胺酶2在非小细胞肺癌患者中的预后价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27d31103e603)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059633, encodeId=19fc2059633bf, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=Ann Oncol：非小细胞肺癌的循环肿瘤细胞系的前瞻性研究, objectType=article, longId=106843, objectId=bad41068439e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bad41068439e, replyNumber=0, likeNumber=59, createdTime=2017-08-29, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bad41068439e, moduleTitle=Ann Oncol：非小细胞肺癌的循环肿瘤细胞系的前瞻性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bad41068439e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059635, encodeId=6c362059635dc, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle= LANCET RESPIR MED :埃克替尼对比全脑照射治疗EGFR突变的非小细胞肺癌合并多发脑肿瘤患者（BRAIN）疗效如何？, objectType=article, longId=107158, objectId=cb6710e1581d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb6710e1581d, replyNumber=0, likeNumber=101, createdTime=2018-01-11, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb6710e1581d, moduleTitle= LANCET RESPIR MED :埃克替尼对比全脑照射治疗EGFR突变的非小细胞肺癌合并多发脑肿瘤患者（BRAIN）疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb6710e1581d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2059699, encodeId=88c920596996b, content=<a href='/topic/show?id=2cc599381bd' target=_blank style='color:#2F92EE;'>#非小细胞#</a>, objectTitle=【盘点】非小细胞肺癌近期重要研究进展一览, objectType=article, longId=135192, objectId=6881135192cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6881135192cb, replyNumber=0, likeNumber=58, createdTime=2018-09-08, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6881135192cb, moduleTitle=【盘点】非小细胞肺癌近期重要研究进展一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6881135192cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

非小细胞

2020-05-29

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

NCCN临床实践指南：非小细胞肺癌（2017.V9）

2018-09-22

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

CLIN CANCER RES：ASP8273治疗EGFR突变非小细胞肺癌

2018-07-02

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

Cancer Cell:新型“液体活检”！非小细胞肺癌诊断准确率高达近90%

2017-09-04

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

ANN ONCOL：S-1与多西他赛治疗铂基化疗后非小细胞肺癌患者的疗效对比

2017-12-29

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

Lung Cancer：安罗替尼可改善晚期非小细胞肺癌患者的生活质量

2019-05-15

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

ADJUVANT研究翻开非小细胞肺癌术后辅助治疗新篇章

2018-12-11

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

JCO：Nivolumab治疗晚期非小细胞肺癌的5 年随访结果

2019-02-11

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

Sci Rep：转录因子PAX6可作为非小细胞肺癌的预后因子和假定肿瘤抑制基因

2018-07-24

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

ROS1阳性非小细胞肺癌诊断病理专家共识

2018-11-19

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

PLoS One：前列腺特异性膜抗原（PSMA）在非小细胞肺癌中的表达

2018-03-25

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

JCO：PD-1抑制剂治疗合并自身免疫疾病的非小细胞肺癌患者

2018-12-06

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

Ann Oncol：我国学者展示非小细胞肺癌的精准治疗方案

2017-07-26

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

JCO：激酶抑制剂可作为EGFR突变阳性晚期非小细胞肺癌的一线治疗！

2018-02-01

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

NEJM：Atezolizumab一线治疗转移性非鳞状非小细胞肺癌

2019-05-19

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

肺癌脑转移该如何治疗？国内非小细胞肺癌脑转移调研发布

2018-10-30

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

Lancet oncol：ALT-803（IL-15强激动剂）联合nivolumab用于转移性非小细胞肺癌安全性可耐受

2018-05-28

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

Oncotarget：转谷氨酰胺酶2在非小细胞肺癌患者中的预后价值

2018-02-20

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

Ann Oncol：非小细胞肺癌的循环肿瘤细胞系的前瞻性研究

2017-08-29

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

LANCET RESPIR MED :埃克替尼对比全脑照射治疗EGFR突变的非小细胞肺癌合并多发脑肿瘤患者（BRAIN）疗效如何？

2018-01-11

lingaifan (审核中...)

前往app查看评论内容

#非小细胞#

【盘点】非小细胞肺癌近期重要研究进展一览

2018-09-08

科室
- - 订阅+
  - 更多科室
工具
服务